These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38366235)

  • 21. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment.
    Tripathi S; Yadav KS
    Daru; 2024 Jun; 32(1):161-175. PubMed ID: 38158475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timolol versus brinzolamide added to travoprost in glaucoma or ocular hypertension.
    Pfeiffer N;
    Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):1065-71. PubMed ID: 21499770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open-angle glaucoma or ocular hypertension maintained on timolol therapy.
    Shin D
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S163-8. PubMed ID: 10665519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patients.
    Martínez A; Sánchez-Salorio M
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):239-48. PubMed ID: 19348600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of single glaucoma drug in combined timolol XE, latanoprost and brinzolamide therapy: a discontinuation study.
    Kobayashi H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):245-50. PubMed ID: 22283238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brinzolamide-timolol fixed combination for the prevention of intraocular pressure elevation after phacoemulsification.
    Georgakopoulos CD; Makri OE; Plotas P; Pharmakakis N
    Clin Exp Ophthalmol; 2013; 41(7):662-7. PubMed ID: 23432730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate.
    Sah AK; Suresh PK
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):448-459. PubMed ID: 27002850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Silver LH
    Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of dorzolamide/timolol vs brinzolamide/brimonidine fixed combination therapy in the management of primary open-angle glaucoma.
    Kozobolis V; Panos GD; Konstantinidis A; Labiris G
    Eur J Ophthalmol; 2017 Mar; 27(2):160-163. PubMed ID: 27445072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular hypotensive effect and safety of brinzolamide ophthalmic solution in open angle glaucoma patients.
    Wang TH; Huang JY; Hung PT; Shieh JW; Chen YF
    J Formos Med Assoc; 2004 May; 103(5):369-73. PubMed ID: 15216404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
    Liu JH; Medeiros FA; Slight JR; Weinreb RN
    Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.
    Danafar H; Sharafi A; Kheiri Manjili H; Andalib S
    Pharm Dev Technol; 2017 Aug; 22(5):642-651. PubMed ID: 26916923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
    Dubey V; Mohan P; Dangi JS; Kesavan K
    Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release.
    Kim HJ; Zhang K; Moore L; Ho D
    ACS Nano; 2014 Mar; 8(3):2998-3005. PubMed ID: 24506583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
    Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
    J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of fixed-combination brinzolamide/timolol in Latin American patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination.
    Alezzandrini A; Hubatsch D; Alfaro R
    Adv Ther; 2014 Sep; 31(9):975-85. PubMed ID: 25138224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport of Vitamin E from Ethanol/Water Solution into Contact Lenses and Impact on Drug Transport.
    Liu Z; Overton M; Chauhan A
    J Ocul Pharmacol Ther; 2022; 38(6):396-403. PubMed ID: 35049374
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucoma.
    Holló G; Chiselita D; Petkova N; Cvenkel B; Liehneova I; Izgi B; Berta A; Szaflik J; Turacli E; Stewart WC
    Eur J Ophthalmol; 2006; 16(6):816-23. PubMed ID: 17191187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.